Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Anne M.
Anne M. Bowcock, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20120077682 | COMPOSITIONS AND METHODS FOR DETECTING CANCER METASTASIS - The present invention encompasses compositions and methods for detecting cancer metastasis. | 03-29-2012 |
Anne M. Gillis, Calgary CA
| Patent application number | Description | Published |
|---|---|---|
| 20100069982 | TIME BASED ARRHYTHMIA THERAPY EFFICACY CRITERIA - An implantable medical device and associated method classify therapy outcomes and heart rhythms in association with therapy outcome. A therapy success time interval is started in response to delivering an arrhythmia therapy. If normal sinus rhythm is detected after the therapy success time interval expires, the delivered therapy is classified as unsuccessful and the detected arrhythmia is classified as a self-terminating rhythm. | 03-18-2010 |
Anne M. Kumor, Greendale, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20110087988 | GRAPHICAL CONTROL ELEMENTS FOR BUILDING MANAGEMENT SYSTEMS - A building management system includes graphical control elements for viewing and interacting with the building management system. Graphical control elements conduct analysis of information received from the building management system and may be used to control building equipment, monitor operational statuses, diagnose faults, or conduct other building management system tasks. | 04-14-2011 |
Anne M. Lemoigne, Ann Arbor, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090240418 | DUAL THROTTLE POSITION SENSOR DIAGNOSTIC SYSTEM WITH REDUCED STALLING - A system includes an out of correlation (OOC) detection module that detects an OOC error between a first throttle position sensor (TPS) and a second TPS. An out of range (OOR) detection module that detects first and second OOR errors for the first and second TPS, respectively. An OOC counter sets an OOC error when an OOC count is greater than or equal to a first OOC value. An OOR counter sets first and second OOR errors when first and second OOR counts, respectively, are greater than or equal to a second OOR value that is less than the first OOC value. A control module increments the counters when the respective errors occur and sets at least one of the first and second OOR counts equal to the OOC count when at least one of the first and second OOR errors occur after the OOC error. | 09-24-2009 |
Anne M. Pentz, Landenberg, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080280370 | METHODS AND COMPOSITIONS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF - The present invention provides various methods and compositions which allow for determining the presence or amount of glyphosate, N-acetylglyphosate, N-acetyl AMPA or aminomethyl phosphoric acid (AMPA) and its various metabolites in a variety of test matrices. In one method, determining the presence or amount of N-acetylglyphosate and/or N-acetyl AMPA in a test sample comprises providing the test sample suspected of containing N-acetylglyphosate and/or N-acetyl AMPA; extracting the N-acetylglyphosate and/or N-acetyl AMPA from the test sample; and, detecting the N-acetylglyphosate and/or N-acetyl AMPA in the extract. In other methods, the presence or amount of at least one of glyphosate, N-acetylglyphosate, N-acetyl AMPA or aminomethyl phosphonic acid (AMPA) or a metabolite thereof in a test sample is determined. The method comprises providing the test sample suspected of containing at least one of glyphosate, N-acetylglyphosate, N-acetyl AMPA or AMPA or a metabolite thereof, extracting from the test sample at least one of the glyphosate, N-acetylglyphosate, N-acetyl AMPA or AMPA; and, detecting at least one of the glyphosate, the N-acetylglyphosate, the N-acetyl AMPA and the AMPA from the test sample; wherein detection of the glyphosate, N-acetylglyphosate, N-acetyl AMPA or AMPA occurs without derivatization of the glyphosate, the N-acetylglyphosate, N-acetyl AMPA or the AMPA. | 11-13-2008 |
Anne M. Pianca, Valencia, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100152818 | NON-LINEAR ELECTRODE ARRAY - A system for stimulation includes an implantable pulse generator, a lead, and conductors. The lead includes an array body disposed at a distal end of the lead and electrodes concentrically arranged on the array body. A center electrode may also be disposed on the array body. The electrodes may be arranged in more than one concentric ring. A method of using an implantable stimulator includes implanting an implantable stimulator and providing an electrical signal to at least one electrode of the implantable stimulator to stimulate a tissue. The electrical signal may be provided between diametrically opposed electrodes or between electrodes that are not diametrically opposed. If the implantable stimulator has a center electrode, the electrical signal may be provided between the center electrode and at least one concentrically arranged electrode. | 06-17-2010 |
| 20110118815 | ELECTRODE ARRAY ASSEMBLY AND METHOD OF MAKING SAME - A lead assembly and a method of making a lead are provided. The method of making a multi-contact lead assembly comprises placing monofilament placed in the void spaces not occupied by the plurality of conductor wires and, in one embodiment, thermally fusing the monofilament to the like material spacer by applying heat just below the melting temperature of the monofilament and spacer material. Alternatively, the monofilament and spacer may be of different materials and heat is applied to cause at least one material to thermally reflow or melt. The conductive contacts may be located at either the distal end and/or proximal end of the lead. Oversized spacers may be used in order to provide extra material to fill voids during the thermal fusion/reflow process. | 05-19-2011 |
| 20110288619 | SYSTEM FOR PERMANENT ELECTRODE PLACEMENT UTILIZING MICROELECTRODE RECORDING METHODS - A lead stimulation/recording system is provided, which is a combination of a permanent DBS stimulating lead and a recording microelectrode. The DBS lead has a lumen extending from the proximal to the distal end of the lead, the lumen having an opening on each end of the lead. The microelectrode is configured and dimensioned to be insertable into the DBS lead from either the distal or proximal opening of the DBS lead, thereby permitting the microelectrode to be placed before, concurrently with, or after placement of the DBS lead. In addition, the system may be used with known microelectrode recording systems and methods of inserting the electrodes, such as the five-at-a-time method, the dual-microdrive method, or the single microdrive method. | 11-24-2011 |
Anne M. Pianca, Santa Monica, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090005823 | LEAD ASSEMBLY FOR IMPLANTABLE MICROSTIMULATOR - A lead assembly for a small implantable medical device (a.k.a, microdevice | 01-01-2009 |
| 20100076535 | LEADS WITH NON-CIRCULAR-SHAPED DISTAL ENDS FOR BRAIN STIMULATION SYSTEMS AND METHODS OF MAKING AND USING - A lead is configured and arranged for brain stimulation. The lead includes a proximal end and a distal end. The proximal end includes a plurality of terminals disposed at the proximal end. The distal end has a non-circular transverse cross-sectional shape and includes a plurality of electrodes disposed at the distal end. A plurality of conductive wires electrically couple at least one of the plurality of electrodes to at least one of the plurality of terminals. | 03-25-2010 |
| 20100114278 | DEPOSITED CONDUCTIVE LAYERS FOR LEADS OF IMPLANTABLE ELECTRIC STIMULATION SYSTEMS AND METHODS OF MAKING AND USING - An implantable lead includes an inner core substrate. A plurality of conductors that include at least one layer of at least one conductive material are deposited on the inner core substrate. A patterned insulator layer is disposed over the conductors such that at least two regions of each conductor remain exposed through the insulator. A patterned terminal layer defines a plurality of separated terminals that are deposited at a proximal end of the lead. At least one terminal is electrically coupled to each conductor via at least one of the exposed regions of the at least one conductor. A patterned electrode layer defines a plurality of separated electrodes that are deposited at a distal end of the lead. At least one electrode is electrically coupled to each conductor via at least one of the exposed regions of the at least one conductor. | 05-06-2010 |
| 20120041497 | LEAD CONNECTOR FOR AN IMPLANTABLE ELECTRIC STIMULATION SYSTEM AND METHODS OF MAKING AND USING - A lead-connection system includes a lead and a connector. The lead includes a distal end, a proximal end, a plurality of electrodes disposed at the distal end, a plurality of terminals disposed at the proximal end, and a plurality of conductor wires electrically coupling each of the plurality of electrodes to a different one of the plurality of terminals. The connector defines a port for receiving the proximal end of the lead and a plurality of connector contacts. The number of connector contacts is greater than the number of terminals disposed on the proximal end of the lead. When the connector receives the proximal end of the lead, each of the terminals disposed on the proximal end of the lead makes electrical contact with at least one of the connector contacts of the connector and no two terminals make electrical contact with a same one of the connector contacts. | 02-16-2012 |
Anne M. Rowzee, Rockville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20110223604 | Assay for the Measurement of IGF Type 1 Receptor and Insulin Receptor Expression - This invention relates to a quantitative PCR assay that differentiates between IR-A, IR-B and IGF-IR mRNAs and compares expression of the three receptors on the same scale. | 09-15-2011 |
Anne M. Shearrow, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20120128551 | IONIC LIQUID MEDIATED SOL-GEL SORBENTS - Ionic liquid (IL)-mediated sol-gel hybrid organic-inorganic materials present enormous potential for effective use in analytical microextraction. One obstacle to materializing this prospect arises from high viscosity of ILs significantly slowing down sol-gel reactions. A method was developed which provides phosphonium-based, pyridinium-based, and imidazolium-based IL-mediated advanced sol-gel organic-inorganic hybrid materials for capillary microextraction. Scanning electron microscopy results demonstrate that ILs can serve as porogenic agents in sol-gel reactions. IL-mediated sol-gel coatings prepared with silanol-terminated polymers provided up to 28 times higher extractions compared to analogous sol-gel coatings prepared without any IL in the sol solution. This study shows that IL-generated porous morphology alone is not enough to provide effective extraction media: careful choice of the organic polymer and the precursor with close sol-gel reactivity must be made to ensure effective chemical bonding of the organic polymer to the created sol-gel material to be able to provide the desired sorbent characteristics. | 05-24-2012 |
Anne M. Shelchuk, Cupertino, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080287818 | PRESSURE MEASUREMENT-BASED ISCHEMIA DETECTION - In some aspects ischemia is indicated based on cardiac pressure measurements. For example, ischemia may be indicated based on an increase in an intraventricular electromechanical delay where mechanical contractions are detected by measuring pressure in a cardiac chamber. Ischemia detection also may involve obtaining timing information relating to a mechanical contraction of at least one ventricle to identify an intraventricular dyssynchrony. In this case, pressure measurements may be used to identify the timing of the mechanical contraction. Ischemia may be indicated based on a change in a time interval associated with a systolic interval of a ventricle. Ischemia also may be indicated based on an intracardiac electrogram-based indication of ischemia in conjunction with an increase in mean left atrial pressure and/or an increase in the size of a v-wave. | 11-20-2008 |
| 20110046492 | MONITORING FOR MITRAL VALVE REGURGITATION - Implantable systems, and methods for use therein, for monitoring for mitral valve regurgitation (MR) are provided. An electrogram (EGM) signal and a corresponding pressure signal are obtained, where the EGM signal is representative of electrical functioning of the patient's heart during a plurality of cardiac cycles, and the corresponding pressure signal is representative of pressure within the left atrium the patient's heart during the cardiac cycles. Windows of the pressure signal are defined, based on events detected in the EGM signal, and measurements from the windows are used to monitor for MR. | 02-24-2011 |
| 20120065532 | Implantable Medical Devices Employing Electroactive Polymers For Sensing Cardiac Motion and/or Causing Cardiac Compression - Disclosed herein is a system for monitoring a motion of a cardiac tissue. The system includes a motion sensor configured to operably couple to the cardiac tissue. The motion sensor includes an electroactive polymer and is further configured to result in a deflection in the electroactive polymer when the cardiac tissue undergoes the motion. The deflection in the electroactive polymer generates an electrical event. | 03-15-2012 |
Anne M. Taylor, San Marino, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080257735 | Microfluidic Device for Enabling the Controlled Growth of Cells and Methods Relating to Same - A multi-compartment microfluidic device for enabling fluidic isolation among interconnected compartments and accomplishing centrifugal positioning and/or patterned substrate positioning of biological specimens. Includes micropatterned substrate coupled with optically transparent housing allowing imaging. Housing includes microfluidic region having entry reservoir for accepting first volume of fluid and additional microfluidic region(s) having a second entry reservoir for accepting second volume of fluid less than first volume of fluid to create hydrostatic pressure. A barrier region that couples the microfluidic region with the second microfluidic region enables biological specimen(s) to extend across the microfluidic, barrier region and second microfluidic region. The barrier region includes embedded microgroove(s) having width and height enabling second volume of fluid to be fluidically isolated from first volume of fluid via hydrostatic pressure maintained via the embedded microgroove(s). Cells are aligned to a chosen location using a centrifuge or patterned substrate techniques. | 10-23-2008 |